<DOC>
	<DOC>NCT01679223</DOC>
	<brief_summary>The purpose of this study is to measure the level of AlloMaxâ„¢ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.</brief_summary>
	<brief_title>Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12</brief_title>
	<detailed_description />
	<criteria>Adult patients (18 70 yrs) who require reconstructive breast surgery with AlloMaxTM implants and agree to participate will be included in this study. Patients who do not agree to be included in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Breast reconstruction</keyword>
	<keyword>Hydroxyproline concentration</keyword>
	<keyword>neoangiogenesis</keyword>
	<keyword>collagen deposition</keyword>
</DOC>